{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:24:04Z","timestamp":1790792644946,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/nrneurol.2015.53","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T11:25:17Z","timestamp":1429615517000},"page":"280-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Multiple sclerosis and pregnancy in the 'treatment era'"],"prefix":"10.1038","volume":"11","author":[{"given":"Sandra","family":"Vukusic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"key":"BFnrneurol201553_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJM199807303390501","volume":"339","author":"C Confavreux","year":"1998","unstructured":"Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P. & Moreau, T. Rate of pregnancy-related relapse in multiple sclerosis. N. Engl. J. Med. 339, 285\u2013291 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201553_CR2","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/brain\/awh152","volume":"127","author":"S Vukusic","year":"2004","unstructured":"Vukusic, S.  et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127, 1353\u20131360 (2004).","journal-title":"Brain"},{"key":"BFnrneurol201553_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1600-0404.2004.00270.x","volume":"110","author":"G Salemi","year":"2004","unstructured":"Salemi, G.  et al. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol. Scand. 110, 23\u201326 (2004).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol201553_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1212\/WNL.0b013e318224afc9","volume":"77","author":"E Portaccio","year":"2011","unstructured":"Portaccio, E.  et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology 77, 145\u2013150 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol201553_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1471-0528.2011.02931.x","volume":"118","author":"A Finkelsztejn","year":"2011","unstructured":"Finkelsztejn, A., Brooks, J. B., Paschoal, F. M. & Fragoso, Y. D. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 118, 790\u2013797 (2011).","journal-title":"BJOG"},{"key":"BFnrneurol201553_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1756285612453192","volume":"5","author":"K Hellwig","year":"2012","unstructured":"Hellwig, K., Haghikia, A., Rockhoff, M. & Gold, R. Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. Ther. Adv. Neurol. Disord. 5, 247\u2013253 (2012).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"BFnrneurol201553_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1177\/1352458513507816","volume":"20","author":"SE Hughes","year":"2014","unstructured":"Hughes, S. E.  et al. Predictors and dynamics of post-partum relapses in women with multiple sclerosis. Mult. Scler. 20, 739\u2013746 (2014).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1468-1331.2006.01108.x","volume":"13","author":"MH Saraste","year":"2006","unstructured":"Saraste, M. H., Kurki, T. & Airas, L. M. Postpartum activation of multiple sclerosis: MRI imaging and immunological characterization of a case. Eur. J. Neurol. 13, 93\u2013102 (2006).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201553_CR9","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1468-1331.2007.01927.x","volume":"14","author":"T Paavilainen","year":"2007","unstructured":"Paavilainen, T.  et al. Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis. Eur. J. Neurol. 14, 1216\u20131221 (2007).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201553_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clineuro.2012.04.024","volume":"115","author":"YD Fragoso","year":"2012","unstructured":"Fragoso, Y. D.  et al. The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis. Clin. Neurol. Neurosurgery 115, 154\u2013159 (2012).","journal-title":"Clin. Neurol. Neurosurgery"},{"key":"BFnrneurol201553_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jnnp.2008.163816","volume":"81","author":"MB D'hooghe","year":"2010","unstructured":"D'hooghe, M. B., Nagels, G. & Uitdehaag, B. M. Long-term effects of childbirth in MS. J. Neurol. Neurosurg. Psychiatry 81, 38\u201341 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201553_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/1352458513519840","volume":"20","author":"DH Miller","year":"2014","unstructured":"Miller, D. H., Fazekas, F., Montalban, X., Reingold, S. C. & Trojano, M. Pregnancy, sex and hormonal factors in multiple sclerosis. Mult. Scler. 20, 527\u2013536 (2014).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijoa.2005.10.010","volume":"15","author":"E Drake","year":"2006","unstructured":"Drake, E., Drake, M., Bird, J. & Russell, R. Obstetric regional blocks for women with multiple sclerosis: a survey of UK experience. Int. J. Obstet. Anesth. 15, 115\u2013123 (2006).","journal-title":"Int. J. Obstet. Anesth."},{"key":"BFnrneurol201553_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1471-2377-12-165","volume":"12","author":"L Pasto","year":"2012","unstructured":"Pasto, L.  et al. for the MS Study Group of the Italian Neurological Society. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol. 12, 165\u2013171 (2012).","journal-title":"BMC Neurol."},{"key":"BFnrneurol201553_CR15","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1007\/s00415-013-7035-7","volume":"260","author":"E Lu","year":"2013","unstructured":"Lu, E.  et al. Obstetrical epidural and spinal anesthesia in multiple sclerosis. J. Neurol. 260, 2620\u20132628 (2013).","journal-title":"J. Neurol."},{"key":"BFnrneurol201553_CR16","unstructured":"World Health Organization. Infant and young child nutrition. Global strategy on infant and young child feeding \n                    [online]\n                    \n                  , (2002)."},{"key":"BFnrneurol201553_CR17","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1177\/1352458513505161","volume":"19","author":"A Langer-Gould","year":"2013","unstructured":"Langer-Gould, A. & Hellwig, K. One can prevent post-partum MS relapses by exclusive breastfeeding: yes. Mult. Scler. 19, 1567\u20131568 (2013).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR18","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1177\/1352458513503054","volume":"19","author":"S Vukusic","year":"2013","unstructured":"Vukusic, S., Confavreux, C. One can prevent post-partum MS relapses by exclusive breastfeeding: no. Mult. Scler. 19, 1565\u20131566 (2013).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR19","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1177\/1352458513504329","volume":"19","author":"M Hutchinson","year":"2013","unstructured":"Hutchinson, M. One can prevent post-partum MS relapses by exclusive breast feeding: commentary. Mult. Scler. 19, 1569\u20131570 (2013).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJM199807303390509","volume":"339","author":"JN Whitaker","year":"1998","unstructured":"Whitaker, J. N. Effects of pregnancy and delivery on disease activity in multiple sclerosis. N. Engl. J. Med. 339, 339\u2013340 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201553_CR21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/archneurol.2009.132","volume":"66","author":"A Langer-Gould","year":"2009","unstructured":"Langer-Gould, A.  et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch. Neurol. 66, 958\u2013963 (2009).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201553_CR22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0b013e3181eb5860","volume":"75","author":"L Airas","year":"2010","unstructured":"Airas, L., Jalkanen, A., Alanen, A., Pirttila, T. & Marttila, R. J. Breastfeeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurology 75, 474\u2013476 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol201553_CR23","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1212\/WNL.0b013e318210e908","volume":"76","author":"RF Neuteboom","year":"2011","unstructured":"Neuteboom, R. F. & Hintzen, R. Q. Breastfeeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurology 76, 1532 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol201553_CR24","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1007\/s00415-012-6553-z","volume":"259","author":"J Pakpoor","year":"2012","unstructured":"Pakpoor, J.  et al. Breastfeeding and multiple sclerosis relapses: a meta-analysis. J. Neurol. 259, 2246\u20132248 (2012).","journal-title":"J. Neurol."},{"key":"BFnrneurol201553_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1212\/WNL.0b013e3181ed3d37","volume":"75","author":"BC Kieseier","year":"2010","unstructured":"Kieseier, B. C. & Wiendl, H. Postpartum disease activity and breastfeeding in multiple sclerosis revisited. Neurology 75, 392\u2013393 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol201553_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10072-006-0676-x","volume":"27","author":"P Cavalla","year":"2006","unstructured":"Cavalla, P.  et al. Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol. Sci. 27, 231\u2013239 (2006).","journal-title":"Neurol. Sci."},{"key":"BFnrneurol201553_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.clim.2013.02.001","volume":"149","author":"K Hellwig","year":"2013","unstructured":"Hellwig, K. & Correale, J. Artificial reproduction techniques in multiple sclerosis. Clin. Immunol. 149, 219\u2013224 (2013).","journal-title":"Clin. Immunol."},{"key":"BFnrneurol201553_CR28","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1212\/01.wnl.0000208521.10685.a6","volume":"66","author":"DA Laplaud","year":"2006","unstructured":"Laplaud, D. A., Leray, E., Barriere, P., Wiertlewski, S. & Moreau, T. Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology 66, 1280\u20131281 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol201553_CR29","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00415-008-0607-2","volume":"255","author":"K Hellwig","year":"2008","unstructured":"Hellwig, K.  et al. Increased MS relapse rate during assisted reproduction technique. J. Neurol. 255, 592\u2013593 (2008).","journal-title":"J. Neurol."},{"key":"BFnrneurol201553_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000177937","volume":"61","author":"K Hellwig","year":"2009","unstructured":"Hellwig, K., Schimrigk, S., Beste, C., Muller, T. & Gold, R. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur. Neurol. 61, 65\u201368 (2009).","journal-title":"Eur. Neurol."},{"key":"BFnrneurol201553_CR31","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/jnnp-2012-302235","volume":"83","author":"L Michel","year":"2012","unstructured":"Michel, L.  et al. on behalf of the Club Francophone de la Sclerose En Plaques (CFSEP). Increased risk of multiple sclerosis relapse after in vitro fertilization. J. Neurol. Neurosurg. Psychiatry 83, 796\u2013802 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201553_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/ana.23745","volume":"72","author":"J Correale","year":"2012","unstructured":"Correale, J., Farez, M. F. & Ysrraelit, M. C. Increase in multiple sclerosis activity after assisted reproduction technology. Ann. Neurol. 72, 682\u2013694 (2012).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201553_CR33","unstructured":"Food and Drug Administration, Department of Health and Human Services. Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling \n                    [online]\n                    \n                  , (2008)."},{"key":"BFnrneurol201553_CR34","unstructured":"European Medicines Agency. Guideline on risk assessment of medicinal products on human reproduction and lactation: from data to labelling. \n                    [online]\n                    \n                  , (2005)."},{"key":"BFnrneurol201553_CR35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jamaneurol.2014.209","volume":"71","author":"A Haghikia","year":"2014","unstructured":"Haghikia, A.  et al. Natalizumab use during the third trimester of pregnancy. JAMA Neurol. 71, 891\u2013895 (2014).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol201553_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1056\/NEJMoa020696","volume":"348","author":"DH Miller","year":"2003","unstructured":"Miller, D. H.  et al. for the International Natalizumab Multiple Sclerosis Trial Group. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348, 15\u201323 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201553_CR37","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1212\/WNL.0b013e31821e7c8a","volume":"76","author":"PW O'Connor","year":"2011","unstructured":"O'Connor, P. W.  et al. Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology. 76, 1858\u20131865 (2011).","journal-title":"Neurology."},{"key":"BFnrneurol201553_CR38","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ana.22074","volume":"68","author":"J Killestein","year":"2010","unstructured":"Killestein, J.  et al. Natalizumab drug holiday in multiple sclerosis: poorly tolerated. Ann. Neurol. 68, 392\u2013395 (2010).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201553_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jns.2011.05.043","volume":"308","author":"A Kerbrat","year":"2011","unstructured":"Kerbrat, A.  et al. Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients. J. Neurol. Sci. 308, 98\u2013102 (2011).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol201553_CR40","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1177\/1352458511411064","volume":"17","author":"C Papeix","year":"2011","unstructured":"Papeix, C., Depaz, R., Tourbah, A., Stankoff, B. & Lubetzki, C. Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse. Mult. Scler. 17, 1520\u20131522 (2011).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR41","doi-asserted-by":"publisher","unstructured":"Martinelli, V.  et al. Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning. Mult. Scler. \n                    http:\/\/dx.doi.org\/10.1177\/1352458513492246\n                    \n                  .","DOI":"10.1177\/1352458513492246"},{"key":"BFnrneurol201553_CR42","doi-asserted-by":"publisher","unstructured":"Vukusic, S.  et al. Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis. Mult. Scler. \n                    http:\/\/dx.doi.org\/10.1177\/1352458514554056\n                    \n                  .","DOI":"10.1177\/1352458514554056"},{"key":"BFnrneurol201553_CR43","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1111\/ene.12195","volume":"20","author":"AP Sempere","year":"2013","unstructured":"Sempere, A. P., Berenguer-Ruiz, L. & Feliu-Rey, E. Rebound of disease activity during pregnancy after withdrawal of fingolimod. Eur. J. Neurol. 20, e109\u2013e110 (2013).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201553_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","volume":"62","author":"L Park-Wyllie","year":"2000","unstructured":"Park-Wyllie, L. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62, 385\u2013392 (2000).","journal-title":"Teratology"},{"key":"BFnrneurol201553_CR45","doi-asserted-by":"publisher","first-page":"585.e1","DOI":"10.1016\/j.ajog.2007.05.046","volume":"197","author":"SL Carmichael","year":"2007","unstructured":"Carmichael, S. L.  et al. for the National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am. J. Obstet. Gynecol. 197, 585.e1\u2013585.e7 (2007).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrneurol201553_CR46","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1503\/cmaj.101063","volume":"183","author":"A Hviid","year":"2011","unstructured":"Hviid, A. & Molgaard-Nielsen, D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ 183, 796\u2013804 (2011).","journal-title":"CMAJ"},{"key":"BFnrneurol201553_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/CLEP.S46893","volume":"5","author":"AM Bjorn","year":"2013","unstructured":"Bjorn, A. M., Nielsen, R. B., Norgaard, M., Nohr, E. A. & Ehrenstein, V. Risk of miscarriage among users of corticosteroid hormones: a population-based nested case-control study. Clin. Epidemiol. 5, 287\u2013294 (2013).","journal-title":"Clin. Epidemiol."},{"key":"BFnrneurol201553_CR48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-004-0495-z","volume":"251","author":"A Achiron","year":"2004","unstructured":"Achiron, A.  et al. Effect of intravenous immunoglobulin treatment on pregnancy and post-partum related relapses in multiple sclerosis. J. Neurol. 251, 1133\u20131137 (2004).","journal-title":"J. Neurol."},{"key":"BFnrneurol201553_CR49","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s00415-004-0496-y","volume":"251","author":"C Confavreux","year":"2004","unstructured":"Confavreux, C. Intravenous immunoglobulins, pregnancy and multiple sclerosis. J. Neurol. 251, 1138\u20131139 (2004).","journal-title":"J. Neurol."},{"key":"BFnrneurol201553_CR50","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1177\/1352458506075654","volume":"13","author":"J Haas","year":"2007","unstructured":"Haas, J. & Hommes, O. R. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult. Scler. 13, 900\u2013908 (2007).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1756285608100416","volume":"2","author":"K Hellwig","year":"2009","unstructured":"Hellwig, K., Beste, C., Schimrigk, S. & Chan, A. Immunomodulation and postpartum relapses in patients with multiple sclerosis. Ther. Adv. Neurol. Disord. 2, 7\u201311 (2009).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"BFnrneurol201553_CR52","first-page":"1","volume":"3","author":"YD Fragoso","year":"2014","unstructured":"Fragoso, Y. D.  et al. Postpartum treatment with immunoglobulin does not prevent relapses of multiple sclerosis in the mother. Health Care Women Int. 3, 1\u20139 (2014).","journal-title":"Health Care Women Int."},{"key":"BFnrneurol201553_CR53","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1191\/1352458504ms1079sr","volume":"10","author":"J De S\u00e8ze","year":"2004","unstructured":"De S\u00e8ze, J.  et al. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult. Scler. 10, 596\u2013597 (2004).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR54","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ana.10301","volume":"52","author":"NL Sicotte","year":"2002","unstructured":"Sicotte, N. L.  et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol. 52, 421\u2013428 (2002).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201553_CR55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jns.2009.08.056","volume":"286","author":"S Vukusic","year":"2009","unstructured":"Vukusic, S.  et al. The prevention of post-partum relapses with progestin and estradiol in multiple sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J. Neurol. Sci. 286, 114\u2013118 (2009).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol201553_CR56","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1177\/1352458512471880","volume":"19","author":"BAC Cree","year":"2013","unstructured":"Cree, B. A. C. Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis. Mult. Scler. 19, 835\u2013843 (2013).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR57","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"D Wingerchuk","year":"2007","unstructured":"Wingerchuk, D.  et al. The spectrum of neuromyelitis optica. Lancet Neurol. 6, 805\u2013815 (2007).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201553_CR58","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1212\/WNL.0b013e31824c466f","volume":"78","author":"B Bourre","year":"2012","unstructured":"Bourre, B.  et al. Neuromyelitis optica and pregnancy. Neurology 78, 875\u2013879 (2012).","journal-title":"Neurology"},{"key":"BFnrneurol201553_CR59","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1212\/WNL.0b013e318250d812","volume":"78","author":"W Kim","year":"2012","unstructured":"Kim, W.  et al. Influence of pregnancy on neuromyelitis optica spectrum disorder. Neurology 78, 1264\u20131267 (2012).","journal-title":"Neurology"},{"key":"BFnrneurol201553_CR60","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1007\/s00415-013-7031-y","volume":"260","author":"YD Fragoso","year":"2013","unstructured":"Fragoso, Y. D.  et al. Neuromyelitis optica and pregnancy. J. Neurol. 260, 2614\u20132619 (2013).","journal-title":"J. Neurol."},{"key":"BFnrneurol201553_CR61","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijoa.2012.06.002","volume":"21","author":"N Sadana","year":"2012","unstructured":"Sadana, N.  et al. Anesthetic management of a parturient with neuromyelitis optica. Int. J. Obstet. Anesth. 21, 371\u2013375 (2012).","journal-title":"Int. J. Obstet. Anesth."},{"key":"BFnrneurol201553_CR62","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1177\/1352458511401945","volume":"17","author":"T Ritzenthaler","year":"2011","unstructured":"Ritzenthaler, T.  et al. First attack of Devic's neuromyelitis optica following endovascular treatment and rupture of brain arteriovenous malformation. Mult. Scler. 17, 895\u2013896 (2011).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR63","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.4049\/jimmunol.1301483","volume":"191","author":"S Saadoun","year":"2013","unstructured":"Saadoun, S.  et al. Neuromyelitis optica IgG causes placental inflammation and fetal death. J. Immunol. 191, 2999\u20133005 (2013).","journal-title":"J. Immunol."},{"key":"BFnrneurol201553_CR64","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1212\/WNL.0000000000000911","volume":"83","author":"N Asgari","year":"2014","unstructured":"Asgari, N., Henriksen, T. B., Petersen, T., Lillevang, S. T. & Weinshenker, B. G. Pregnancy outcomes in a woman with neuromyelitis optica. Neurology 83, 1576\u20131577 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol201553_CR65","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.msard.2012.06.002","volume":"1","author":"DJ Kimbrough","year":"2012","unstructured":"Kimbrough, D. J.  et al. Treatment of neuromyelitis optica: review and recommendations. Mult. Scler. Relat. Disord. 1, 180\u2013187 (2012).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"BFnrneurol201553_CR66","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1177\/1352458509106512","volume":"15","author":"HL Pellkofer","year":"2009","unstructured":"Pellkofer, H. L.  et al. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab. Mult. Scler. 15, 1006\u20131008 (2009).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR67","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1177\/1352458513498125","volume":"19","author":"M Ringelstein","year":"2013","unstructured":"Ringelstein, M.  et al. Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum. Mult. Scler. 19, 1544\u20131547 (2013).","journal-title":"Mult. Scler."},{"key":"BFnrneurol201553_CR68","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","volume":"359","author":"A Compston","year":"2002","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet 359, 1221\u20131231 (2002).","journal-title":"Lancet"},{"key":"BFnrneurol201553_CR69","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/bfm.2011.0044","volume":"7","author":"TW Hale","year":"2012","unstructured":"Hale, T. W.  et al. Transfer of interferon \u03b2-1a into human breastmilk. Breastfeed Med. 7, 123\u2013125 (2012).","journal-title":"Breastfeed Med."},{"key":"BFnrneurol201553_CR70","unstructured":"Multiple Sclerosis Trust UK. Pregnancy and parenthood fact sheet \n                    [online]\n                    \n                  , (2014)."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.53","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:17:25Z","timestamp":1684469845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2015.53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFnrneurol201553"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2015.53","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]},"assertion":[{"value":"21 April 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.V. has received consulting and lecture fees, travel grants and research support from Bayer-Schering, Biogen Idec, Genzyme, Novartis, Merck Serono, Sanofi Aventis and Teva Pharma. R.M. has received consulting and lecture fees, travel grants and research support from Bayer-Schering, Biogen Idec, Genzyme, Novartis, Merck Serono, Sanofi Aventis and Teva Pharma, and serves in the advisory board of MedImmune.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}